Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel to discuss Lilly's lung cancer drug approval
FDA panel to discuss Lilly's lung cancer drug approval
FDA panel to discuss Lilly's lung cancer drug approval
Submitted by
admin
on June 2, 2015 - 4:57pm
Source:
Yahoo/Reuters
News Tags:
FDA
advisory panels
Eli Lilly
necitumumab
lung cancer
Headline:
FDA panel to discuss Lilly's lung cancer drug approval
Do Not Allow Advertisers to Use My Personal information
